Cargando…
Impact of COVID-19-associated anxiety on the adherence to intravitreal injection in patients with macular diseases a year after the initial outbreak
BACKGROUND: As the primary burden of treating COVID-19 patients began to ease in the United Kingdom, ophthalmology clinic volume within the National Health Service has since recovered. Alarmingly, the rate of non-attendance remains higher than the pre-pandemic level. PURPOSE: The purpose was to asse...
Autores principales: | Liu, Siyin, Ng, Jonathan K.Y., Moon, Emily Haejoon, Morgan, Daisy, Woodhouse, Natalie, Agrawal, Dakshita, Chan, Laura, Chhabra, Ramandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808017/ https://www.ncbi.nlm.nih.gov/pubmed/35128306 http://dx.doi.org/10.1177/25158414211070881 |
Ejemplares similares
-
Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort
por: Liu, Siyin, et al.
Publicado: (2022) -
Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014) -
Real-world outcomes of combined therapy of photodynamic therapy with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy
por: Liu, Siyin, et al.
Publicado: (2021) -
Intravitreal gas injection for the treatment of diabetic macular edema
por: McHugh, Dominic, et al.
Publicado: (2011) -
Macular Hole Progression following Ocriplasmin Intravitreal Injection
por: Casswell, Edward, et al.
Publicado: (2014)